跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,543 条关于
“Sareum Holdings”
全部
3,543
临床试验
2,458
药物
151
机构
162
资讯
772
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
Sareum Holdings Raises £2.4 Million to Advance TYK2/JAK1 Inhibitor SDC-1801
11个月前
Sareum Halts SDC-1801 Toxicology Study Due to Animal Welfare Concerns, Phase 2 Psoriasis Trial Delayed
去年
Sareum Partners with Receptor.AI to Accelerate AI-Driven Discovery of Brain-Penetrating TYK2/JAK1 Inhibitors for Neuroinflammatory Diseases
2个月前
Sareum Completes Dosing in Phase 2-Enabling Toxicology Programme for TYK2/JAK1 Inhibitor SDC-1801
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
2年前
Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma
去年
ALX Oncology's Evorpacept Shows Promise in Multiple Cancer Trials
去年
CERO Therapeutics' CER-1236 Receives FDA Clearance for Clinical Trials
第 1 页,共 78 页
上一页
下一页